@article{TGH5683,
author = {Helmut Friess and Florian Scheufele},
title = {Pancreatic cancer},
journal = {Translational Gastroenterology and Hepatology},
volume = {5},
number = {0},
year = {2020},
keywords = {},
abstract = {Malignant tumors of the pancreas—mainly pancreatic ductal adenocarcinoma (PDAC)—display a significant cancer burden to the population with an incidence of ~12.1/100,000 and a mortality of ~11.1/100,000 (1). In the Western world and in Germany, PDAC is currently ranked fourth place for causing cancer-related deaths (1,2). Furthermore, due to the increasing prevalence of PDAC and the stagnation in treatment strategies, PDAC is expected to reach rank two of cancer-related deaths by the year of 2030 (2).},
issn = {2415-1289}, url = {https://tgh.amegroups.org/article/view/5683}
}